Cart
sales@molnova.com
JBSNF-000088
CAS No. 7150-23-4
JBSNF-000088 ( JBSNF 000088; JBSNF000088 )
Catalog No. M24726 CAS No. 7150-23-4
JBSNF-000088 is an Nicotinamide N-methyltransferase (NNMT)inhibitor. It is used for the treatment of metabolic disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 35 | In Stock |
|
| 200MG | 50 | In Stock |
|
| 500MG | 82 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJBSNF-000088
-
NoteResearch use only, not for human use.
-
Brief DescriptionJBSNF-000088 is an Nicotinamide N-methyltransferase (NNMT)inhibitor. It is used for the treatment of metabolic disorders.
-
DescriptionJBSNF-000088 is an Nicotinamide N-methyltransferase (NNMT)inhibitor. It is used for the treatment of metabolic disorders.
-
SynonymsJBSNF 000088; JBSNF000088
-
PathwayOthers
-
TargetOther Targets
-
RecptorNNMT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number7150-23-4
-
Formula Weight152.2
-
Molecular FormulaC7H8N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (657.25 mM)
-
SMILESO=C(N)C1=CN=C(OC)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kannt A, Rajagopal S, Kadnur SV, Suresh J, Bhamidipati RK, Swaminathan S, Hallur MS, Kristam R, Elvert R, Czech J, Pfenninger A, Rudolph C, Schreuder H, Chandrasekar DV, Mane VS, Birudukota S, Shaik S, Zope BR, Burri RR, Anand NN, Thakur MK, Singh M, Parveen R, Kandan S, Mullangi R, Yura T, Gosu R, Ruf S, Dhakshinamoorthy S. A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders. Sci Rep. 2018 Feb 26;8(1):3660. doi: 10.1038/s41598-018-22081-7.
molnova catalog
related products
-
Quercetin-3-O-β-D-gl...
Quercetin-3-O-β-D-glucose-7-O-β-D-gentiobiosiden is a flavonoid from Quercetin.
-
ODQ
ODQ is an effective and selective soluble guanylyl cyclase (sGC) inhibitor.
-
Yamogenin
Yamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
